Sara Erika Bellomo

6PUBLICATIONS
96CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsOncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 22, 2025
The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Marco Avolio, Simonetta M Leto, Francesco Sassi

|May 02, 2023
BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.

Annalisa Petrelli, Sabrina Rizzolio, Filippo Pietrantonio

|Feb 08, 2023
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.

Lorenzo Castagnoli, Simona Corso, Alma Franceschini

|Nov 22, 2022
HER2 Copy Number and Resistance Mechanisms in Patients with HER2-positive Advanced Gastric Cancer Receiving Initial Trastuzumab-based Therapy in JACOB Trial.

Filippo Pietrantonio, Paolo Manca, Sara Erika Bellomo

|Feb 05, 2021
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas.

Simona Corso, Filippo Pietrantonio, Maria Apicella

Pageof 1